KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Non-Current Assets (2016 - 2025)

Thermo Fisher Scientific's Other Non-Current Assets history spans 17 years, with the latest figure at $5.9 billion for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 30.7% year-over-year to $5.9 billion, compared with a TTM value of $5.9 billion through Dec 2025, up 30.7%, and an annual FY2025 reading of $5.9 billion, up 30.7% over the prior year.
  • Other Non-Current Assets for Q4 2025 was $5.9 billion at Thermo Fisher Scientific, up from $5.0 billion in the prior quarter.
  • The five-year high for Other Non-Current Assets was $5.9 billion in Q4 2025, with the low at $2.5 billion in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $4.2 billion, with a median of $4.3 billion recorded in 2022.
  • Year-over-year, Other Non-Current Assets skyrocketed 88.85% in 2021 and then decreased 13.64% in 2022.
  • Tracing TMO's Other Non-Current Assets over 5 years: stood at $4.6 billion in 2021, then fell by 13.64% to $4.0 billion in 2022, then decreased by 0.2% to $4.0 billion in 2023, then rose by 12.33% to $4.5 billion in 2024, then soared by 30.7% to $5.9 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Other Non-Current Assets are $5.9 billion (Q4 2025), $5.0 billion (Q3 2025), and $4.6 billion (Q2 2025).